Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Pancreatic hormones Stories

2013-10-31 10:24:53

Scientists from the Helmholtz Zentrum München (HMGU) and the Technische Universität München (TUM), together with scientists in the USA, have developed a new therapeutic approach for treatment of type 2 diabetes. A novel single molecule hormone, which acts equally on the receptors of the insulin-stimulating hormones GLP-1 and GIP, was observed to reduce weight and improve blood sugar. The results have now been published in the medical journal 'Science Translational Medicine', and include...

Rare Tumor Caused Woman To Act Drunk As Blood Sugar Plummets
2013-07-18 11:15:51

redOrbit Staff & Wire Reports - Your Universe Online For nearly two years, a New York woman would randomly begin acting as though she were drunk or crazy, until doctors at the Mount Sinai Medical Center discovered the cause of her malady -- a rare, mysterious tumor on her pancreas that caused her blood sugar to unexpectedly plummet. The patient, a 54-year-old Rockland County realtor named Rosemary McGinn, would experience episodes during which she would talk to herself or sway...

2013-06-20 16:27:50

-- Xeris Pharmaceuticals, Inc., and LATITUDE Pharmaceuticals, Inc., will develop two different formulations of soluble glucagon for use in infusion pumps, and better determine their impact in regulating blood-glucose levels in people with type 1 diabetes-- NEW YORK, June 20, 2013 /PRNewswire-USNewswire/ -- JDRF announced today partnerships with both Xeris Pharmaceuticals, Inc., and LATITUDE Pharmaceuticals, Inc. (LPI), to support the development soluble glucagon formulations--an...

2012-12-18 05:01:06

This trial is a 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naïve subjects with T2DM inadequately controlled on a maximum tolerated dose or maximum dose according to local label of GLP-1 receptor agonist and metformin. Birmingham, Alabama (PRWEB) December 17, 2012 For information about how to participate in this type 2 diabetes clinical trial, visit Achieve Clinical Research or contact us directly at (205) 380-6434 Type...

2012-12-07 08:24:23

CARLSBAD, Calif., Dec. 7, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today positive results from Phase 1 studies of three drugs, ISIS-PTP1B(Rx), ISIS-GCGR(Rx) and ISIS-GCCR(Rx), in development to treat metabolic disorders, including type 2 diabetes. In all three Phase 1 studies, the drugs were safe and well tolerated with early encouraging data that supports the unique mechanism of each drug. All three drugs are part of Isis' metabolic franchise and are designed...

2012-10-05 10:22:28

DANBURY, Conn., Oct. 5, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today announced it will be hosting a meeting for analysts and investors on October 11, 2012 in New York. During the meeting, independent experts in the field of diabetes will provide an overview of the unmet medical needs and review the therapeutics in development as they relate to Biodel's major programs. Biodel's senior management will review the company's pipeline in areas of ultra-rapid-acting insulin, glucagon and...

2012-09-27 02:26:21

DANBURY, Conn., Sept. 27, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) will present experimental data from its ultra-rapid-acting prandial insulin analog program at the 48th annual meeting of the European Association for the Study of Diabetes (EASD) being held October 1-5, 2012 in Berlin, Germany. Biodel Poster # 906 "Development of ultra-rapid-acting prandial insulin analogues requires chelation of zinc ions and charge masking to increase the rate of subcutaneous absorption," Tuesday,...

2012-08-09 23:19:36

Manipulating a group of hormone-producing cells in the brain can control blood sugar levels in the body — a discovery that has dramatic potential for research into weight-loss drugs and diabetes treatment. In a paper published in the October issue of Genetics and available online now, neurobiologists at Wake Forest University examine how fruit flies (Drosophila) react when confronted with a decreased diet. Reduced diet or starvation normally leads to hyperactivity in fruit flies...

2012-07-09 11:24:01

Selectively modifying hormones and using them as medicinal substances Researchers at the RUB and from Berkeley have used metal complexes to modify peptide hormones. In the Journal of the American Chemical Society, they report for the first time on the three-dimensional structure of the resulting metal-peptide compounds. "With this work, we have laid the molecular foundation for the development of better medicines" says Prof. Raphael Stoll from the Faculty of Chemistry and Biochemistry at...

2012-06-12 14:24:43

JDRF-funded researchers from Oregon Health and Science University and Legacy Health discovered a method to stabilize liquid glucagon for automated pump delivery JDRF-funded researchers at Oregon Health & Science University (OHSU) and Legacy Health have discovered a liquid glucagon formulation that may be useable in standard diabetes pumps. Such a formulation could broaden the use of glucagon to help prevent hypoglycemia in people with type 1 diabetes (T1D) who are treated with insulin....


Latest Pancreatic hormones Reference Libraries

Pancreas
2013-01-02 11:22:15

The pancreas is a digestive and an endocrine organ with both endocrine and exocrine functions. It is about six inches long located in the upper portion of the abdominal cavity. The head of the pancreas lies within the indentation of the duodenum and is connected to it by the pancreatic duct. The uncinate process extends from the head and the neck connects to the body of the pancreas, which lies directly behind the stomach. The tail of the pancreas extends to the left side of the body and is...

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (2 articles) »